Texas Yale Capital Corp. - FATE THERAPEUTICS INC ownership

FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 253 filers reported holding FATE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.41 and the average weighting 0.4%.

Quarter-by-quarter ownership
Texas Yale Capital Corp. ownership history of FATE THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$234,000
-1.3%
4,0000.0%0.01%
-7.7%
Q3 2021$237,000
-31.7%
4,0000.0%0.01%
-35.0%
Q2 2021$347,000
+5.2%
4,0000.0%0.02%
-4.8%
Q1 2021$330,000
-9.3%
4,0000.0%0.02%
-12.5%
Q4 2020$364,0004,0000.02%
Other shareholders
FATE THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 3,379,064$200,277,00017.57%
Redmile Group, LLC 12,957,222$767,975,00013.39%
Copernicus Capital Management, LLC 12,000$711,0008.60%
Grosvenor Holdings, L.L.C. 1,037,256$61,478,0007.53%
DAFNA Capital Management LLC 344,360$20,410,0005.42%
Casdin Capital, LLC 3,400,000$201,518,0005.02%
Ally Bridge Group (NY) LLC 270,000$16,003,0004.70%
Darwin Global Management, Ltd. 353,250$20,937,0003.85%
Bellevue Group AG 3,238,036$191,918,0001.95%
Artal Group S.A. 1,450,000$85,942,0001.92%
View complete list of FATE THERAPEUTICS INC shareholders